ARTICLE | Clinical News
Fludase: Phase II data
August 22, 2011 7:00 AM UTC
Top-line data from a double-blind, U.S. Phase II trial in 177 evaluable patients with PCR-confirmed influenza infection showed that once-daily 10 mg DAS181 for 3 days significantly reduced viral load ...